Respiratory syncytial virus (RSV) infection has an estimated global incidence of 33 million
cases in children younger than 5 years, with 10% requiring hospital admission and up to …

Respiratory Syncytial Virus (RSV) is the commonest cause of severe respiratory infection in
infants, leading to over 3 million hospitalizations and around 66,000 deaths worldwide each …

In animal models, resident memory CD8+ T (Trm) cells assist in respiratory virus elimination
but their importance in man has not been determined. Here, using experimental human …

Background Pneumonia is a leading cause of mortality and morbidity in children globally.
The cause of pneumonia after introduction of the 13-valent pneumococcal conjugate …

Respiratory syncytial virus (RSV) is a globally prevalent cause of lower respiratory infection
in neonates and infants. Despite its disease burden, a safe and effective RSV vaccine has …

Respiratory syncytial virus (RSV) is the principal cause of bronchiolitis in infants and a
significant healthcare problem. The RSV Glycoprotein (G) mediates attachment of the virus …

Group B streptococcus and respiratory syncytial virus are leading causes of infant morbidity
and mortality worldwide. No licensed vaccines are available for either disease, but vaccines …

BACKGROUND Respiratory syncytial virus (RSV) is an important cause of acute pulmonary
disease and one of the last remaining major infections of childhood for which there is no …

Respiratory syncytial virus (RSV) and influenza are among the most important causes of
severe respiratory disease worldwide. Despite the clinical need, barriers to developing …

Respiratory syncytial virus (RSV) infects epithelial cells of the respiratory tract and is a major
cause of bronchiolitis and pneumonia in children and the elderly. The virus assembles and …